PMID- 19161344
OWN - NLM
STAT- MEDLINE
DCOM- 20090219
LR  - 20191210
IS  - 1520-6025 (Electronic)
IS  - 0163-3864 (Print)
IS  - 0163-3864 (Linking)
VI  - 72
IP  - 1
DP  - 2009 Jan
TI  - Antimalarial peptides from marine cyanobacteria: isolation and structural 
      elucidation of gallinamide A.
PG  - 14-7
LID - 10.1021/np8003529 [doi]
AB  - As part of a continuing program to identify novel treatments for neglected parasitic 
      diseases, the Panama International Cooperative Biodiversity Group (ICBG) program has 
      been investigating the antimalarial potential of secondary metabolites from 
      Panamanian marine cyanobacteria. From over 60 strains of cyanobacteria evaluated in 
      our biological screens, the organic extract of a Schizothrix species from a tropical 
      reef near Piedras Gallinas (Caribbean coast of Panama) showed potent initial 
      antimalarial activity against the W2 chloroquine-resistant strain of Plasmodium 
      falciparum. Bioassay-guided fractionation followed by 2D NMR analysis afforded the 
      planar structure of a new and highly functionalized linear peptide, gallinamide A. 
      Subsequent degradation and derivatization methods were used to determine the 
      absolute configuration at most stereogenic centers in this unusual new metabolite.
FAU - Linington, Roger G
AU  - Linington RG
AD  - Center for Marine Biotechnology and Biomedicine, Scripps Institution of 
      Oceanography, University of California San Diego, La Jolla, California 92093, USA. 
      rogerl@chemistry.ucsc.edu
FAU - Clark, Benjamin R
AU  - Clark BR
FAU - Trimble, Erin E
AU  - Trimble EE
FAU - Almanza, Alejandro
AU  - Almanza A
FAU - Ureña, Luis-David
AU  - Ureña LD
FAU - Kyle, Dennis E
AU  - Kyle DE
FAU - Gerwick, William H
AU  - Gerwick WH
LA  - eng
GR  - U01 TW006634/TW/FIC NIH HHS/United States
GR  - U01 TW006634-01/TW/FIC NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
TA  - J Nat Prod
JT  - Journal of natural products
JID - 7906882
RN  - 0 (Antimalarials)
RN  - 0 (Antimicrobial Cationic Peptides)
RN  - 0 (Peptides)
RN  - 0 (gallinamide A)
RN  - 886U3H6UFF (Chloroquine)
SB  - IM
MH  - Animals
MH  - Antimalarials/chemistry/*isolation & purification/*pharmacology
MH  - Antimicrobial Cationic Peptides
MH  - Caribbean Region
MH  - Chloroquine/pharmacology
MH  - Cyanobacteria/*chemistry
MH  - Marine Biology
MH  - Molecular Structure
MH  - Nuclear Magnetic Resonance, Biomolecular
MH  - Parasitic Sensitivity Tests
MH  - Peptides/chemistry/*isolation & purification/*pharmacology
MH  - Plasmodium falciparum/*drug effects
PMC - PMC2760338
MID - NIHMS130781
EDAT- 2009/01/24 09:00
MHDA- 2009/02/20 09:00
CRDT- 2009/01/24 09:00
PHST- 2009/01/24 09:00 [entrez]
PHST- 2009/01/24 09:00 [pubmed]
PHST- 2009/02/20 09:00 [medline]
AID - 10.1021/np8003529 [pii]
AID - 10.1021/np8003529 [doi]
PST - ppublish
SO  - J Nat Prod. 2009 Jan;72(1):14-7. doi: 10.1021/np8003529.
